Trial updateRetina

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

Recruiting. Phase 2. Registered enrolment: 60. Genentech, Inc.

Close-up of the iris and pupil
Stock photo · Colin Lloyd / Unsplash

Why it matters

Track this study through NCT05626114. No results are posted in this registry record.

The study at a glance

Registry status
Recruiting
Phase
Phase 2
Registered enrolment
60
Results posted
No
Sponsor
Genentech, Inc.

Keep in mind

Registry information describes the study; recruitment status alone does not establish efficacy or safety.

References (1)
  1. ClinicalTrials.gov · NCT05626114

Source date: 15 Sept 2026 · United States · Israel

Report a correction

Connected reading